![Mark L. Lewis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark L.
Lewis is currently the Executive Chairman at Miroculus, Inc. He previously worked as the Director at Swift Biosciences, Inc. from 2017 to 2021.
He also held the position of General Manager & Vice President at BD Biosciences Clontech.
Postes actifs de Mark L. Lewis
| Sociétés | Poste | Début |
|---|---|---|
Miroculus, Inc.
 Miroculus, Inc. Packaged SoftwareTechnology Services Develops software tools for biotechnology company | Président | 19/04/2022 |
Anciens postes connus de Mark L. Lewis
| Sociétés | Poste | Fin |
|---|---|---|
Swift Biosciences, Inc.
 Swift Biosciences, Inc. BiotechnologyHealth Technology Develops molecular biology reagents | Directeur Général | 01/01/2018 |
BD Biosciences Clontech
 BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
BD Biosciences Clontech
BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Health Technology |
Swift Biosciences, Inc.
Swift Biosciences, Inc. BiotechnologyHealth Technology Develops molecular biology reagents | Health Technology |
Miroculus, Inc.
Miroculus, Inc. Packaged SoftwareTechnology Services Develops software tools for biotechnology company | Technology Services |
